Clinical Trials in Milwaukee, WI

Browse 237 Clinical Trials Milwaukee Across 1023 Cities
102 Phase 3 Trial · 10456 Clinical Trials Milwaukee Clinics

Display Results

All

Most EffectiveMost SafeSenior FriendlyPediatricNo Placebo

Clinical Trials Clinical Trials in Milwaukee, WI

Reviewed by Michael Gill, B. Sc.

Image of Boston Children's Hospital in Boston, United States.

Phase-Based Progress Estimates

BEAM-101for Anemia, Sickle Cell

This trial is testing a new treatment for sickle cell disease, which is a genetic disorder that causes red blood cells to become deformed and break down. The new treatment is called BEAM-101 and it uses a patient's own stem cells that have been edited to fix the genetic mutation that causes sickle cell disease.

Boston Children's Hospital (+1 Sites)Beam Therapeutics Inc.

Image of UWM Anxiety Disorders Laboratory in Milwaukee, United States.

Phase-Based Progress Estimates

Response Inhibition Training (RIT)for Obsessive-Compulsive Disorder

The impaired ability to suppress an inappropriate but pre-potent response (response inhibition; RI) characterizes several debilitating clinical problems, including obsessive-compulsive and related disorders (OCRD) such as obsessive-compulsive disorder, trichotillomania, and skin picking disorder. There is a critical need to develop an effective and durable treatment for OCRDs with demonstrable evidence for improving impaired RI. The purpose of our project is to examine the impact of a novel computerized intervention, response inhibition training (RIT), on neural indices of RI, and examine the mechanistic link between engagement of the neural RI targets and change in OCRD symptoms. To this end, this project will conduct a randomized clinical trial for individuals with OCD, trichotillomania, and/or skin picking disorders. Participants will be randomly assigned to 8 to 16 sessions of computerized RIT or a computerized placebo training. Various clinical, behavioral, and brain-imaging data will be acquired to evaluate the training effects at baseline, post-training, and 1-month follow-up periods.

UWM Anxiety Disorders LaboratoryChristine Larson, Ph.D.

Image of Clinical Research Site in Encino, United States.

Phase-Based Progress Estimates

Izokibepfor Hidradenitis Suppurativa

This trial is testing a new drug to treat hidradenitis suppurativa, a painful skin condition. The drug is given as a shot, and the trial will test how well it works and if it has any side effects.

Clinical Research Site (+22 Sites)Paul M Peloso, MD, MSc.ACELYRIN Inc.

Image of Children's Wisconsin in Milwaukee, United States.

Phase-Based Progress Estimates

Long Peripheral Catheterfor Vascular Access Device Complications

This trial is testing whether long peripheral catheters (LPCs) are a safer alternative to peripherally inserted central catheters (PICCs) for medium-term vascular access in hospitalized pediatric patients.

Children's WisconsinAlina Burek

Image of NRG Oncology in Philadelphia, United States.

Phase-Based Progress Estimates

Ipatasertibfor Stage IIIB Ovarian Cancer AJCC v8

This trial is testing the safety and efficacy of combining ipatasertib with paclitaxel and carboplatin to treat ovarian cancer. Ipatasertib works by blocking some of the enzymes needed for cell growth, while paclitaxel and carboplatin work by killing or slowing the growth of tumor cells. The combination of these drugs may be more effective in treating ovarian cancer than paclitaxel and carboplatin alone.

NRG Oncology (+4 Sites)Katherine C Fuh

Image of Prometheus Biosciences Selected Site in Los Angeles, United States.

Phase-Based Progress Estimates

PRA023 IVfor Diffuse Scleroderma

This trial is testing a new drug to see if it's safe and effective for people with a lung disease called SSc-ILD.

Prometheus Biosciences Selected Site (+9 Sites)Prometheus BiosciencesPrometheus Biosciences, Inc.

Image of Arkansas Children's Hospital in Little Rock, United States.

Phase-Based Progress Estimates

Anakinra 8 Mg/kg/dayfor Toxemia

This trial is testing a drug called anakinra to see if it can help reverse severe inflammation in children with sepsis-induced multiple organ dysfunction syndrome (MODS).

Arkansas Children's Hospital (+24 Sites)

Image of Children's Oncology Group in Philadelphia, United States.

Phase-Based Progress Estimates

Radiation Therapyfor Glioblastoma

FDA Approved Drug

This trial is testing the safety and effectiveness of selinexor in combination with radiation therapy in treating children and young adults with newly diagnosed brain cancer.

FDA Approved Drug

Children's Oncology Group (+50 Sites)Adam L Green

Image of Alta Bates Summit Medical Center-Herrick Campus in Berkeley, United States.

Phase-Based Progress Estimates

Pembrolizumabfor Stage IVA Lung Cancer AJCC v8

FDA Approved Drug

This trial is testing immunotherapy treatment with N-803 and pembrolizumab for advanced non-small cell lung cancer. N-803 may activate natural killer cells so that they can stimulate an immune response to help fight cancer. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread.

FDA Approved Drug

Alta Bates Summit Medical Center-Herrick Campus (+99 Sites)John M Wrangle

Image of Littleton Adventist Hospital in Littleton, United States.

Phase-Based Progress Estimates

Quality-of-Life Assessmentfor Glioblastoma

FDA Approved Drug

This trial is comparing the effect of adding lomustine to temozolomide and radiation therapy versus temozolomide and radiation therapy alone in treating newly diagnosed MGMT methylated glioblastoma.

FDA Approved Drug

Littleton Adventist Hospital (+99 Sites)Fabio M Iwamoto

Image of Illinois CancerCare-Bloomington in Bloomington, United States.

Phase-Based Progress Estimates

Cabozantinib S-malatefor Stage III Urethral Cancer AJCC v8

FDA Approved Drug

This trial is testing whether adding cabozantinib to avelumab improves treatment of metastatic urothelial cancer.

FDA Approved Drug

Illinois CancerCare-Bloomington (+99 Sites)Shilpa Gupta

Image of Zablocki Veterans Administration Medical Center in Milwaukee, United States.

Phase-Based Progress Estimates

Quality-of-Life Assessmentfor Oral Squamous Cell Carcinoma

FDA Approved Drug

This trial is testing whether a lower dose of a chemotherapy drug, given more often, is as effective as a higher dose of the drug given less often, in treating patients with head and neck cancer.

FDA Approved Drug

Zablocki Veterans Administration Medical Center (+99 Sites)Paul M Harari

Image of Massachusetts General Hospital in Boston, United States.

Phase-Based Progress Estimates

SRK-181for Malignancies

This trial is testing a new drug, SRK-181, to see if it is safe and effective in treating solid tumors. The study will test different doses of the drug alone and in combination with another anti-cancer drug. The trial is divided into 3 parts, with a long-term extension phase.

Massachusetts General Hospital (+11 Sites)Lu Gan, MDScholar Rock, Inc.

Image of Anchorage Associates in Radiation Medicine in Anchorage, United States.

Phase-Based Progress Estimates

Cisplatinfor Malignant Neoplasms

FDA Approved Drug

This trial is testing whether adding durvalumab to standard chemoradiation followed by additional durvalumab can extend patients life and/or prevent the tumor from coming back compared to the usual approach of chemoradiation alone followed by durvalumab.

FDA Approved Drug

Anchorage Associates in Radiation Medicine (+99 Sites)Nathan A Pennell

Image of Massachusetts General Hospital in Boston, United States.

Phase-Based Progress Estimates

Autologous Genetically Modified ADP-A2M4CD8 Cellsfor Melanoma

This trial will study ADP-A2M4CD8 T-cell therapy, given to people with certain HLA types and tumors that express the MAGE-A4 antigen. Tumor types include endometrial, esophageal, EGJ, gastric, head and neck, melanoma, NSCLC, ovarian, and urothelial cancer.

Massachusetts General Hospital (+11 Sites)David Hong, MDAdaptimmune

Image of Children's Hospital of Alabama in Birmingham, United States.

Phase-Based Progress Estimates

Arm B (SR-Avg Experimental)for Down Syndrome

FDA Approved Drug

This trial is studying how well blinatumomab works with chemotherapy in treating patients with newly diagnosed B-cell acute lymphoblastic leukemia or B-lymphoblastic lymphoma.

FDA Approved Drug

Children's Hospital of Alabama (+99 Sites)Sumit Gupta

Image of The Angeles (Cedars-Sinai Medical Center and its Affiliates) in Los Angeles, United States.

Phase-Based Progress Estimates

Wide Local Excision = 1cm Marginfor Melanoma

This trial is testing whether a less radical surgery is just as effective as a more radical surgery for melanoma.

The Angeles (Cedars-Sinai Medical Center and its Affiliates) (+55 Sites)Marc Moncrieff

Image of Anchorage Associates in Radiation Medicine in Anchorage, United States.

Phase-Based Progress Estimates

Pembrolizumabfor Stage IIIB Lung Cancer AJCC v8

FDA Approved Drug

This trial is studying whether giving first-line pembrolizumab followed by pemetrexed and carboplatin with or without pembrolizumab works better in treating patients with advanced non-squamous non-small cell lung cancer.

FDA Approved Drug

Anchorage Associates in Radiation Medicine (+99 Sites)Hossein Borghaei

Image of Anchorage Associates in Radiation Medicine in Anchorage, United States.

Phase-Based Progress Estimates

Cisplatinfor Intrahepatic Cholangiocarcinoma

Waitlist Available

FDA Approved Drug

This trial is studying gemcitabine hydrochloride, cisplatin, and nab-paclitaxel to see how well they work in treating patients with biliary tract cancer.

Waitlist Available

FDA Approved Drug

Anchorage Associates in Radiation Medicine (+99 Sites)Rachna Shroff

Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Phase-Based Progress Estimates

Pembrolizumabfor Melanoma

Waitlist Available

FDA Approved Drug

This trial is testing whether giving the immunotherapy drug pembrolizumab before and after surgery is better than giving it just after surgery for treating patients with high-risk melanoma.

Waitlist Available

FDA Approved Drug

University of Alabama at Birmingham Cancer Center (+99 Sites)Sapna P Patel

Image of GastroIntestinal Biosciences in Los Angeles, United States.

Phase-Based Progress Estimates

BMS-986165for Granulomatous Colitis

This trial is testing a potential new Crohn's Disease treatment to see if it is safe and effective.

GastroIntestinal Biosciences (+51 Sites)Bristol-Myers SquibbBristol-Myers Squibb

Image of Froedtert Hospital and the Medical College of Wisconsin in Milwaukee, United States.

Phase-Based Progress Estimates

Antitumor Bfor Mouth Neoplasms

This trial is designed to see the effects of an oral agent on cancer patients between the time of their cancer diagnosis and their cancer surgery.

Froedtert Hospital and the Medical College of WisconsinStuart Wong, MD

Image of Children's Hospital of Alabama in Birmingham, United States.

Phase-Based Progress Estimates

Arm A (imatinib Mesylate, EsPhALL Chemotherapy)for T Acute Lymphoblastic Leukemia

FDA Approved Drug

This trial is studying the combination of imatinib mesylate with two different chemotherapy regimens to treat patients with newly diagnosed Philadelphia chromosome positive acute lymphoblastic leukemia.

FDA Approved Drug

Children's Hospital of Alabama (+99 Sites)Lewis B Silverman, MD

Image of Research Site in Birmingham, United States.

Phase-Based Progress Estimates

Part A: Treatment Group 1for Liver Cirrhosis

This is a two part Phase IIa/b multicentre, randomised, double-blind, placebo-controlled, parallel group dose-ranging study to assess the efficacy, safety, and tolerability of the combination of zibotentan and dapagliflozin, and dapagliflozin monotherapy versus placebo in participants with cirrhosis with features of portal hypertension.

Research Site (+7 Sites)AstraZeneca

Image of Boston Children's Hospital in Boston, United States.

Phase-Based Progress Estimates

Autologous CD34+ HSC Cells Transduced With The Lentiviral Vector Containing A ShRNA Targeting BCL11afor Anemia, Sickle Cell

This trial is testing a new way to treat sickle cell disease that involves changing the patient's own genes to try to cure the disease.

Boston Children's Hospital (+9 Sites)David Williamsbluebird bio

25 Clinical Trials Milwaukee Near Me

Top Cities for Clinical Trials Milwaukee

Image of Milwaukee in Wisconsin.

Milwaukee

193Active Trials

Medical College of WisconsinTop Active Site

Image of New York in New York.

New York

189Active Trials

Memorial Sloan Kettering Cancer CenterTop Active Site